JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Whitepaper
Phenotypic drug discovery with high content screening
Today's drug discovery strategies require candidate compounds to fail early and cheaply in the discovery stage, rather than late and expensively in the clinical phase. Testing compounds early in physiologically relevant model systems and leveraging rich information from image-based screens are ways of focusing on those compounds that give rise to the right phenotypic changes without undesirable effects on the system.
Learn:
- Why you should consider phenotypic vs. target-based drug discovery strategies
- Challenges you should be aware of for phenotypic assays
- How to maximize the return on your phenotypic assays
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Phenotypic drug discovery with high content screening